Detalhe da pesquisa
1.
Regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantation.
Blood
; 143(16): 1656-1669, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38295333
2.
γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma.
Blood
; 134(19): 1585-1597, 2019 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558469
3.
The α-emitter astatine-211 targeted to CD38 can eradicate multiple myeloma in a disseminated disease model.
Blood
; 134(15): 1247-1256, 2019 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31395601
4.
CD38-bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B-cell malignancies.
Blood
; 131(6): 611-620, 2018 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29158362
5.
Development of [211At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignancies.
Leukemia
; 36(6): 1485-1491, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35474099
6.
A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641E.
Cancer Res
; 65(15): 6631-9, 2005 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16061643